Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma

Chin Med J (Engl). 1999 Jun;112(6):493-6.

Abstract

Objective: To address whether circulating T-cells from the patients with primary and metastatic malignant melanoma show altered chemotaxis to monocyte-chemotactic protein 1 (MCP-1) and its relation to tumor infiltrating lymphocyte (TIL) and metastasis.

Methods: Chemotactic response of T-cells towards MCP-1 and immuno-histochemistry study of TIL and tumor-associated-macrophages (TAM) were investigated in patients with primary and metastatic melanoma compared to patients with basal cell carcinoma and healthy persons.

Results: T-cells from patients with primary and metastatic melanoma showed a significantly decreased chemotactic migration towards MCP-1 and T-cells from patients with basal cell carcinoma showed normal chemotactic response. Immuno-histochemistry study showed that there was no correlation between the number of TIL and the decreased chemotaxis of circulating T-cells to MCP-1 in patients with primary melanoma.

Conclusions: Circulating T-cells from patients with primary and metastatic melanoma showed a MCP-1-specific decrease in chemotactic migration. This may be due to abnormal expression or modulation of MCP-1-receptor expression on these cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chemokine CCL2 / immunology*
  • Chemotaxis, Leukocyte*
  • Female
  • Humans
  • Lymphocyte Subsets / immunology
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Macrophages / immunology
  • Male
  • Melanoma / immunology*
  • Melanoma / secondary
  • Middle Aged
  • Skin Neoplasms / immunology
  • T-Lymphocytes / immunology*

Substances

  • Chemokine CCL2